Baradács, I.; Teutsch, B.; Vincze, Á.; Hegyi, P.; Szabó, B.; Nyirády, P.; Ács, N.; Melczer, Z.; Bánhidy, F.; Lintner, B.
Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 1776.
https://doi.org/10.3390/jcm14051776
AMA Style
Baradács I, Teutsch B, Vincze Á, Hegyi P, Szabó B, Nyirády P, Ács N, Melczer Z, Bánhidy F, Lintner B.
Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025; 14(5):1776.
https://doi.org/10.3390/jcm14051776
Chicago/Turabian Style
Baradács, István, Brigitta Teutsch, Ádám Vincze, Péter Hegyi, Bence Szabó, Péter Nyirády, Nándor Ács, Zsolt Melczer, Ferenc Bánhidy, and Balázs Lintner.
2025. "Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 14, no. 5: 1776.
https://doi.org/10.3390/jcm14051776
APA Style
Baradács, I., Teutsch, B., Vincze, Á., Hegyi, P., Szabó, B., Nyirády, P., Ács, N., Melczer, Z., Bánhidy, F., & Lintner, B.
(2025). Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 14(5), 1776.
https://doi.org/10.3390/jcm14051776
